ZEPP · Zepp Health Corp
$4.43
+0.08 (+1.84%)
At close · Jul 30
Market Cap
$64.38M
Shares
14.66M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$258.9M
+41.8%
FY2025
Net Income
-$40.07M
+47.1%
FY2025
Gross Margin
38.31%
-0.2pp
FY2025
Operating Margin
-11.29%
+14.6pp
FY2025
Diluted EPS
-$0.16
+44.8%
FY2025
Operating Cash Flow
-$25.69M
-5.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $258.9M | $182.6M | $2.5B | $4.14B | $6.25B | $6.43B | $5.81B | $3.65B | $2.05B | $1.56B | $896.46M | |
| CNY | — | — | — | — | — | 46.12M | 33.48M | 11.6M | 3M | 754K | 255K |
| $159.71M | $112.37M | $1.84B | $3.34B | $4.94B | $5.1B | $4.34B | $2.71B | $1.55B | $1.28B | $785.87M | |
| $99.19M | $70.23M | $92.36M | $118.86M | $1.31B | $1.33B | $1.47B | $939.45M | $494.7M | $276.15M | $110.59M | |
| 38.31% | 38.46% | 3.7% | 2.87% | 20.89% | 20.71% | 25.25% | 25.77% | 24.14% | 17.74% | 12.34% | |
| $45.32M | $46.16M | $51.5M | $77.3M | $515.08M | $538.01M | $430.82M | $263.22M | $153.83M | $132.3M | $61.55M | |
| $53.83M | $46.47M | $44.53M | $68.31M | $438.27M | $358.66M | $181.98M | $96.54M | $44.03M | $27.82M | $19.17M | |
| $29.27M | $24.85M | $26.78M | $35.11M | $258.35M | $261.81M | $248.46M | $213.97M | $114.88M | $102.64M | $69.98M | |
| $2.83M | $2.45M | $2.49M | $2.56M | $16.78M | $12.18M | $7.81M | $443K | $175K | — | — | |
| $4.54M | $5.02M | $7.69M | $8.71M | $51.88M | $27.13M | $17.22M | $6.22M | — | — | — | |
| $128.42M | $117.48M | $122.81M | $180.71M | $1.21B | $1.16B | $861.26M | $573.73M | $312.73M | $262.77M | $150.71M | |
| -$29.23M | -$47.25M | -$30.45M | -$61.86M | $93.94M | $174.2M | $606.48M | $365.72M | $181.97M | $13.38M | -$40.11M | |
| -11.29% | -25.88% | -1.22% | -1.49% | 1.5% | 2.71% | 10.43% | 10.03% | 8.88% | 0.86% | -4.47% | |
| -$24.7M | -$42.23M | -$22.76M | -$53.15M | $145.83M | $201.33M | $623.7M | $371.94M | — | — | — | |
| $5.7M | $5.55M | $47.7M | $57M | $44.88M | $22.62M | — | — | — | — | — | |
| -$2.07M | -$4.21M | $1.11M | $2.68M | $41.03M | -$4.75M | -$1.11M | $1.74M | $2.81M | -$1.83M | — | |
| CNY | — | — | — | — | — | — | — | 7.86M | — | — | — |
| -$35.46M | -$57.9M | -$34.63M | -$55.89M | $106.67M | $265.61M | $652.37M | $386.61M | $191.9M | $28.86M | -$38.75M | |
| $2.54M | $13.69M | -$2.43M | -$9.87M | $10.75M | $31.15M | $77.89M | $52.04M | $27.61M | $3.09M | -$897K | |
| -$40.07M | -$75.73M | -$31.02M | -$43.24M | $137.8M | $228.75M | $575.2M | $340.05M | $167.68M | $23.95M | -$37.85M | |
| -15.48% | -41.47% | -1.24% | -1.04% | 2.2% | 3.56% | 9.9% | 9.33% | 8.18% | 1.54% | -4.22% | |
| — | -$75K | -$66K | -$103K | -$851K | $953K | -$1.83M | -$3.73M | -$587K | — | — | |
| -$40.07M | -$75.73M | -$31.02M | -$43.24M | $137.8M | $228.75M | $572.75M | $113.49M | $46.12M | -$12.12M | -$61.25M | |
| -$38.46M | -$101.9M | -$42.7M | -$65.15M | $122.45M | $162.3M | $589.14M | $415.09M | $173.99M | $29.51M | -$27.63M | |
| USD/shares | -$0.16 | -$0.29 | -$0.13 | -$0.18 | $2.20 | $3.68 | $9.40 | $2.16 | $2.72 | -$0.88 | -$4.88 |
| USD/shares | -$0.16 | -$0.29 | -$0.13 | -$0.18 | $2.08 | $3.52 | $8.96 | $2.04 | $2.60 | -$0.88 | -$4.88 |
| shares | 254.43M | 258.88M | 243.14M | 246.28M | 63.04M | 62.12M | 60.91M | 52.97M | 16.94M | 13.9M | 12.51M |
| shares | 254.43M | 258.88M | 243.14M | 246.28M | 66.09M | 65.09M | 63.99M | 56.26M | 19.07M | 13.9M | 12.51M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $55.58M in buybacks, $10.84M in dividends.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Europe | $110,266,000 | $74,883,000 | $134,554,000 | $185,244,000 |
| Asia Pacific | $91,480,000 | $75,532,000 | $180,971,000 | $373,988,000 |
| North America | $46,852,000 | $27,371,000 | $33,129,000 | $53,611,000 |
| United States | $43,624,000 | $27,192,000 | — | — |
| Other | $10,299,000 | $4,817,000 | $4,206,000 | $798,000 |
By Product & Service (CNY)
| Component | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Manufactured Product Other | 1,850,443,000 | 2,445,809,000 | 2,909,252,000 | 1,995,282,000 | 1,618,590,000 | 1,205,801,000 |
| Product | 644,879,000 | 1,697,053,000 | 3,340,857,000 | 4,438,081,000 | 4,193,665,000 | 2,439,534,000 |